The Serotonin Syndrome
N Engl J Med 2005;352:1112-20.
Clinical triad of the serotonin syndrome:
- Mental-status changes
agitation and delirium
- Autonomic hyperactivity
tachycardia, mydriasis, diaphoresis, the presence of bowel sounds and diarrhea
- Neuromuscular abnormalities
Hyperreflexia, inducible clonus, myoclonus, ocular clonus, spontaneous clonus, peripheral hypertonicity, and shivering
Diagnosis
- The presence of tremor, clonus, or akathisia without additional EPS should consider the diagnosis.
- Physical examination should include a focused assessment of DTR, clonus, and muscle rigidity, in addition to an evaluation of the size and reactivity of the pupils, the dryness of the oral mucosa, the intensity of bowel sounds, skin color, and the presence or absence of diaphoresis.
QJM 2003;96:635-42
Differential Diagnosis
Condition
|
Serotonin
syndrome
|
Anticholinergic
“toxidrome”
|
NMS
|
Malignant
hyperthermia
|
Medication
History
|
Proserotonergic
drug
|
Anticholinergic
agent
|
Dopamine
antagonist
|
Inhalational
anesthesia
|
Onset
|
<12 hr
|
<12 hr
|
1–3 days
|
30 min to 24 hr
|
Vital Signs
|
Hypertension, tachycardia,
tachypnea,
Hyperthermia (>41.1°C)
|
Hypertension (mild),
tachycardia, tachypnea,
hyperthermia
(typically < 38.8°C)
|
Hypertension, tachycardia,
tachypnea,
hyperthermia
(>41.1°C)
|
Hypertension, tachycardia,
tachypnea, hyperthermia
(can be as high as (46.0°C)
|
Pupils
|
Mydriasis
|
Mydriasis
|
Normal
|
Normal
|
Mucosa
|
Sialorrhea
|
Dry
|
Sialorrhea
|
Normal
|
Skin
|
Diaphoresis
|
Erythema, hot
and dry
|
Pallor, diaphoresis
|
Mottled,
diaphoresis
|
Bowel
Sounds
|
Hyperactive
|
Decreased
or absent
|
Normal or
decreased
|
Decreased
|
Neuromuscular
Tone
|
Increased, predominantly
in lower extremities
|
Normal
|
“Lead-pipe” rigidity present in all muscle groups
|
Rigor mortis–like
rigidity
|
Reflexes
|
Hyperreflexia,
clonus
|
Normal
|
Bradyreflexia
|
Hyporeflexia
|
Mental Status
|
Agitation,
coma
|
Agitated
delirium
|
Stupor, alert
Mutism, coma
|
Agitation
|
Management
1. Removal of the precipitating drugs
2. Provision of supportive care
3. Control of agitation
Control of agitation with benzodiazepines is essential in the management of the serotonin syndrome, regardless of its severity.
Physical restraints are ill-advised and may contribute to mortality by enforcing isometric muscle contractions that are associated with severe lactic acidosis and hyperthermia.4. Administration of 5-HT2a antagonists
Cyproheptadine
Initial dose: po 12 mg and then 2 mg q2h if symptoms continueOlanzapine, sublingual 10 mg
Maintenance dose: po 8 mg q6h
5. Control of autonomic instabilityChlorpromazine, intramuscular 50-100 mg
Hypotension should be treated with low doses of direct-acting sympathomimetic amines (e.g., norepinephrine, phenylephrine, and epinephrine).
Hypertension and tachycardia should be treated with short-acting agents such as nitroprusside and esmolol.6. Control of hyperthermia
In severely ill patients with hyperthermia (temperature >41.1°C), immediate paralysis should be induced with non-depolarizing agents such as vecuronium, followed by orotracheal intubation and ventilation.
There is no role for antipyretic agents in the management of the serotonin syndrome.相關文章:SSRI & Serotonin Syndrome (中文 prezi 版)